81 related articles for article (PubMed ID: 20506320)
1. In vivo relationship between thalamic nicotinic acetylcholine receptor occupancy rates and antiallodynic effects in a rat model of neuropathic pain: persistent agonist binding inhibits the expression of antiallodynic effects.
Ueda M; Iida Y; Yoneyama T; Kawai T; Ogawa M; Magata Y; Saji H
Synapse; 2011 Jan; 65(1):77-83. PubMed ID: 20506320
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acetylcholine receptors expressed in the ventralposterolateral thalamic nucleus play an important role in anti-allodynic effects.
Ueda M; Iida Y; Tominaga A; Yoneyama T; Ogawa M; Magata Y; Nishimura H; Kuge Y; Saji H
Br J Pharmacol; 2010 Mar; 159(6):1201-10. PubMed ID: 20136830
[TBL] [Abstract][Full Text] [Related]
3. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
[TBL] [Abstract][Full Text] [Related]
4. 5-Iodo-A-85380, a specific ligand for alpha 4 beta 2 nicotinic acetylcholine receptors, prevents glutamate neurotoxicity in rat cortical cultured neurons.
Ueda M; Iida Y; Kitamura Y; Kawashima H; Ogawa M; Magata Y; Saji H
Brain Res; 2008 Mar; 1199():46-52. PubMed ID: 18269932
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.
Saji H; Ogawa M; Ueda M; Iida Y; Magata Y; Tominaga A; Kawashima H; Kitamura Y; Nakagawa M; Kiyono Y; Mukai T
Ann Nucl Med; 2002 May; 16(3):189-200. PubMed ID: 12126044
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
Zhu CZ; Chin CL; Rustay NR; Zhong C; Mikusa J; Chandran P; Salyers A; Gomez E; Simler G; Lewis LG; Gauvin D; Baker S; Pai M; Tovcimak A; Brown J; Komater V; Fox GB; Decker MW; Jacobson PB; Gopalakrishnan M; Lee CH; Honore P
Biochem Pharmacol; 2011 Oct; 82(8):967-76. PubMed ID: 21620806
[TBL] [Abstract][Full Text] [Related]
8. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT.
Mamede M; Ishizu K; Ueda M; Mukai T; Iida Y; Fukuyama H; Saga T; Saji H
J Nucl Med; 2004 Sep; 45(9):1458-70. PubMed ID: 15347712
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [(123)I]5IA.
Matsuura Y; Ueda M; Higaki Y; Watanabe K; Habara S; Kamino S; Saji H; Enomoto S
Nucl Med Biol; 2016 Jun; 43(6):372-8. PubMed ID: 27260778
[TBL] [Abstract][Full Text] [Related]
10. α4β2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of α4β2 nAChR agonists in pain.
Lee CH; Zhu C; Malysz J; Campbell T; Shaughnessy T; Honore P; Polakowski J; Gopalakrishnan M
Biochem Pharmacol; 2011 Oct; 82(8):959-66. PubMed ID: 21763685
[TBL] [Abstract][Full Text] [Related]
11. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.
Bannon AW; Decker MW; Curzon P; Buckley MJ; Kim DJ; Radek RJ; Lynch JK; Wasicak JT; Lin NH; Arnold WH; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):787-94. PubMed ID: 9580627
[TBL] [Abstract][Full Text] [Related]
12. 5-[123I]Iodo-A-85380: assessment of pharmacological safety, radiation dosimetry and SPECT imaging of brain nicotinic receptors in healthy human subjects.
Ueda M; Iida Y; Mukai T; Mamede M; Ishizu K; Ogawa M; Magata Y; Konishi J; Saji H
Ann Nucl Med; 2004 Jun; 18(4):337-44. PubMed ID: 15359928
[TBL] [Abstract][Full Text] [Related]
13. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats.
Okada M; Nakagawa T; Minami M; Satoh M
J Pharmacol Exp Ther; 2002 Oct; 303(1):66-73. PubMed ID: 12235234
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide.
Kaufmann D; Yagen B; Minert A; Tal M; Devor M; Bialer M
Neuropharmacology; 2008 Mar; 54(4):699-707. PubMed ID: 18201732
[TBL] [Abstract][Full Text] [Related]
15. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
Holdridge SV; Cahill CM
Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
[TBL] [Abstract][Full Text] [Related]
16. Loss of functional neuronal nicotinic receptors in dorsal root ganglion neurons in a rat model of neuropathic pain.
Dubé GR; Kohlhaas KL; Rueter LE; Surowy CS; Meyer MD; Briggs CA
Neurosci Lett; 2005 Mar; 376(1):29-34. PubMed ID: 15694269
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of α4β2* nicotinic acetylcholine receptors: Desformylflustrabromine potentiates antiallodynic response of nicotine in a mouse model of neuropathic pain.
Bagdas D; Ergun D; Jackson A; Toma W; Schulte MK; Damaj MI
Eur J Pain; 2018 Jan; 22(1):84-93. PubMed ID: 28809075
[TBL] [Abstract][Full Text] [Related]
18. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
[TBL] [Abstract][Full Text] [Related]
19. The antiallodynic effect of Neurotropin is mediated via activation of descending pain inhibitory systems in rats with spinal nerve ligation.
Okazaki R; Namba H; Yoshida H; Okai H; Miura T; Kawamura M
Anesth Analg; 2008 Sep; 107(3):1064-9. PubMed ID: 18713930
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor redistribution in the dorsal root ganglia correlates with neuropathic pain inhibition after resiniferatoxin treatment.
Tender GC; Li YY; Cui JG
Spine J; 2010 Aug; 10(8):715-20. PubMed ID: 20452292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
